Michael Reece's Contact Details

Michael Reece's Company Details

iCubate

Huntsville, AL, US • 20 - 49 Employees
BioTech/Drugs

Rapid Syndromic Testing for All LabsThe mission of iCubate® is to provide rapid, accurate and affordable syndromic testing to all laboratories to ensure care providers have the right tools to improve care and outcomes for their patients. The iCubate® team has developed the iC System™, a low-cost, fully automated, molecular diagnostic platform using armPCR technology, along with a suite of syndromic infectious diseases panels, including sepsis/positive blood cultures, upper / lower respiratory tract infections, GI, mycobacteria, and more.Why iCubate for your lab?• Rapid syndromic testing for infectious diseases for better care, sooner• Affordable system increasing accessibility for large and small labs• Multiplex assay with high target specificity and sensitivity for actionable results• 3 minutes of hands-on time with routine lab processesTwitter: @iCubateFDA Cleared ProductsiC-System™ (iCubate's platform)iC-GPC Assay™ for Gram positive cocciAnticipated clearance 2019iC-GN Assay™ for Gram negative rodsRobust Assay Pipeline GI, Respiratory, Mycobacterium